Schedule 13G ownership disclosure

Immunome Inc

Security class unavailable · CUSIP: 45257U108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,131,568
Percent of class
5.2100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-24-001066
Form type
SC 13G
Filer
Immunome Inc.
CIK
CIK 1472012
Filed
Nov 12, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub